Kala Bio Inc.

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

US-Canada trade tensions intensified after last-minute negotiations collapsed, triggering 50% US tariffs on roughly C$28 billion of Canadian goods and a pledge of equivalent retaliation from Prime Minister Mark Carney. Representative image.

US-Canada trade deal falls apart at the deadline as 50% tariffs revive economic confrontation

Three-year Bar rule reduced as Supreme Court creates new Civil Judge recruitment pathway

Telangana pharma factory explosion kills two workers and leaves two critically burned

Alvotech (Nasdaq: ALVO) lands $150m Lotus biosimilar deal across US, Asia

Kala Bio launches $10m registered direct financing amid balance sheet reset and dilution concerns

Find out how Kala Bio’s $10 million at-the-market stock offering under Nasdaq rules is reshaping its balance sheet, dilution risk, and survival strategy.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynyz
ZYNRELEF
Zynga

December 4, 2025